Liam Ratcliffe - 31 Mar 2026 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Rogan Nunn, by power of attorney
Issuer symbol
OKUR
Transactions as of
31 Mar 2026
Net transactions value
$0
Form type
4
Filing time
01 Apr 2026, 17:25:43 UTC
Previous filing
13 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Liam Ratcliffe filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 01 Apr 2026."

Quick Takeaways

  • This page summarizes Liam Ratcliffe's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 01 Apr 2026, 17:25.

What Changed

  • Previous filing in this sequence was filed on 13 Jun 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ratcliffe Liam Director C/O ONKURE THEREAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER /s/ Rogan Nunn, by power of attorney 01 Apr 2026 0001547100

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OKUR Stock Option (right to buy) Award +15,300 $0.000000* 15,300 31 Mar 2026 Class A Common Stock 15,300 $4.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest on April 30, 2026 and on the last day of each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Sponsored